BARCLAYS PLC

Position in ACIU — AC Immune SA

CIK 312069 LONDON, X0

Position in ACIU

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,924

+$7,443 QoQ

Shares Held

5,791

+114.4% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. ACIU ranks #315 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,924	5,791	+114.4%	Shares	Defined	2026-05-15
2025-12-31	$8,481	2,701	-48.9%	Shares	Sole	2026-02-13
2025-09-30	$15,287	5,290	-33.1%	Shares	Sole	2026-03-31
2025-06-30	$16,051	7,907	+6.7%	Shares	Sole	2026-02-27
2025-03-31	$13,854	7,409	+26.2%	Shares	Sole	2026-03-17
2024-12-31	$15,854	5,872	+1098.4%	Shares	Sole	2026-03-19
2024-09-30	$1,852	490	-93.1%	Shares	Sole	2026-03-31
2021-09-30	$47,424	7,068	+5889.8%	Shares	Sole	2021-11-09
2021-06-30	$935	118	-69.9%	Shares	Sole	2021-08-13
2021-03-31	$2,983	392	+269.8%	Shares	Sole	2021-05-13
2020-12-31	$548	106	0.0%	Shares	Sole	2021-02-11
2020-09-30	$517	106	0.0%	Shares	Sole	2020-11-12
2020-06-30	$713	106	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.